A five-year study into the mechanisms by which cancer cells become mobile and start spreading has implications for the way in which aggressive prostate...
Interview with Dr Axel Gräwingholt, Clinical Co-Chair of the Guidelines Development Group (GDG) at the European Commission Initiative on Breast Cancer and AI
Researchers have developed a new method of quickly generating T-cells, which are used in cancer immunotherapy to destroy tumour cells.
In the September issue of...
Researchers from the University of Cambridge, UK, have developed a new gold nanotube that can heat and kill cancer cells.
More than 2,600 people are...
Dr Michele Bernasconi from the Department for BioMedical Research (DBMR) at the University of Bern, discusses the potential for nanomedicine and immunotherapies to offer...
Sarah Killcoyne, Postdoctoral Fellow at EMBL’s European Bioinformatics Institute, discusses a newly-developed statistical model that uses genomic sequencing to accurately predict the risk of...
Atomic physicists and nuclear medicine experts at the University of Tokyo and the National Institute of Radiological Sciences (NIRS) have devised a simple way...
Researchers led by the Spanish National Research Council (CSIC) has designed new hydrogels that facilitate the growth of T-lymphocytes (T-cells), which are used to...
An increased awareness on a molecular level of the mechanisms prostate cancer cells use to become mobile and start spreading could provide new opportunities...